Rapaport, Samuel I.
October 1959
Angiology;Oct1959, Vol. 10 Issue 5, p391
Academic Journal
Discusses the relationships between blood clotting in vitro and intravascular blood clotting. Explanation on the mechanisms for in vitro clotting; Emphasis on the importance of circulating tissue thromboplastin in producing hypercoagulability; Recognition of all factors necessary for rapid clotting.


Related Articles

  • Validity of International Normalized Ratio in Expressing Prothrombin Times in Anticoagulated and Nonanticoagulated Patients. Alshameeri, Rasheed; Mammen, Eberhard F.; Paisley, Christa; Perry, Christine // Clinical & Applied Thrombosis/Hemostasis;Winter1996, Vol. 2 Issue 1, p25 

    We investigated the effect of four thromboplastins with different International Sensitivity Index (ISI) values on prothrombin times (PTs), expressed as International Normalized Ratios (INRs), of 30 normal plasmas, 30 patients on stable oral anticoagulant (OA) therapy, and 30 patients with...

  • THE EFFECT OF REPOSITORY HEPARIN UPON LIPOPROTEIN PATTERNS IN HUMAN BEINGS. Loewe, Leo; Richmond, Gilbert; Brown, B. S. Raymond; Lasser, Richard P.; Cohen, Clifford; Cox, Herald // Angiology;Aug1953, Vol. 4 Issue 4, p295 

    In this study the marked effect of repository heparin upon the lipoprotein pattern of human beings has been demonstrated. It thus constitutes a confirmation of the initial observation of Graham et al. (7) in this regard. We have observed that the most pronounced effect is upon the lipoproteins...

  • Use of recombinant factor VIIa for emergency reversal of anticoagulation. Ingerslev, J.; Vanek, T.; Culic, S. // Journal of Postgraduate Medicine;Jan-Mar2007, Vol. 53 Issue 1, p17 

    Context: There is limited data regarding the use of activated recombinant factor VII (rFVIIa) in anticoagulated patients requiring reversal. Aims: To identify and describe characteristics of subjects who received rFVIIa as part of emergency treatment aimed at improving hemostasis. Settings and...

  • Tissue factor inflammatory response regulated by promoter genotype and p38 MAPK in neonatal vs. adult microvascular endothelial cells. Buzby, Jeffrey; Williams, Shirley; Imfeld, Karen; Kunicki, Thomas; Nugent, Diane // Inflammation Research;Apr2014, Vol. 63 Issue 4, p299 

    Objective and design: Variable tissue factor (TF) expression by human microvascular endothelial cells (HMVEC) may be regulated by two promoter haplotypes, distinguished by an 18-basepair deletion ( D) or insertion ( I) at −1,208. We sought to determine the relationship between these...

  • Who Ya Gonna Call? Clot Busters! Brynie, Faith Hickman // 101 Questions about Blood & Circulation;2001, p83 

    This article focuses on the paradox of blood clotting. Since the 1950s, scientists have been looking for ways to understand the clotting that saves lives and prevents the clotting that ends them. An equation is formulated to summarize the process of blood clotting. In 1977, scientists used a...

  • Review of Continuing Education Course on Hemostasis. Baker, Dale C.; Brassard, Jacqueline // Toxicologic Pathology;1/1/2011, Vol. 39 Issue 1, p281 

    The continuing education course �Hemostasis� provided a comprehensive review of hemostasis and selected perturbations of the underlying processes as well as an assessment of hemostasis in animal models and preclinical testing environments. The session began with a review of the current...

  • Tromboelastografía: nuevos conceptos en la fisiología de la hemostasia y su correlación con la coagulopatía asociada al trauma. Galvez, Kenny; Cortes, Claudia // Colombian Journal of Anesthesiology / Revista Colombiana de Anes;ago-oct2012, Vol. 40 Issue 3, p224 

    Initial interpretation of the process of coagulation refers to two pathways: (1) the extrinsic pathway, consisting of tissue factor (TF) and factor VII, and (2) the intrinsic pathway, in which factors XII, XI, IX, VIII and V are involved. Currently, this concept has changed and it is accepted...

  • Haemostasis screening. Moore, Gary W.; Rangarajan, Savita // British Journal of Hospital Medicine (17508460);Aug2009, Vol. 70 Issue 8, pM116 

    The article discusses the haemostasis screening process. It states that pairing of coagulation screen and platelet count are important for first-line screening of haemostasis. It notes that mixed studies could determine whether an elevated prothrombin time or activated partial thromboplastin...

  • Using activated factor VII in ob/gyn practice. Paidas, Michael J.; Rosenman, Stephen; Hossain, Nazli // Contemporary OB/GYN;Oct2007, Vol. 52 Issue 10, p46 

    This article describes the role of activated recombinant FVII (rFVIIa) in blood clotting. This agent acts in two stages and its local effects have profound indirect system effects. rFVIIa exerts an influence on Tissue Factor (TF)-bearing cell surfaces and thrombin-activated platelets. Blood...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics